PE Ratio
212.63
EPS
$0.0990
Market Cap
$4.8B
52 Week Range
$14.77 - $24.65
Operating Margin
11.29%
Dividend & Yield
$0 (0.00%)
Volume
NaN
Rev. per Share
$1.34

About Abcam plc

Abcam plc, a life sciences company, researches, develops, and distributes biological reagents and tools for research, drug discovery, and diagnostics in the United States, China, Japan, Europe, the Middle East, Africa, and rest of Asia Pacific. The company offers various research products, including primary and secondary antibodies; ELISA and matched antibody pairs; cell and tissue imaging tools; cellular and biochemical assays; proteins and peptides; proteomics tools; agonists, antagonists, activators, and inhibitors; cell line and lysates; and multiplex assays. Its research products are used in the areas of cancer, cardiovascular, cell biology, developmental biology, epigenetics, nuclear signaling, immunology, metabolism, microbiology, neuroscience, signal transduction, and stem cells. Further, the company offers diagnostic and therapeutic solutions. It also sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.

Earnings

News about Abcam plc

Abcam plc
Type
Sector
Healthcare
Industry
Biotechnology